PTCT vs TROW · rev $633.1M vs P/E 12, rev $3.76B
PTC Therapeutics Inc (PTCT) versus T. Rowe Price Group Inc (TROW) — a side-by-side from cached financials, not a winner call.
PTC Therapeutics Inc (PTCT) is a biotechnology company listed on NASDAQ.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
Latest reported PTCT revenue for 2026-06-30 was $633.1M. Net income was $80.7M. PTCT currently screens at market cap $6.51B.
Latest reported TROW revenue for 2026-06-30 was $3.76B. Net income was $1.13B. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
PTCT currently screens at market cap $6.51B. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Not investment advice. Open the PTCT and TROW stock pages for the full models.
Not investment advice.